"L'hôpital Lyon-Sud dispose de services d’excellence, notamment dans les domaines de la cancérologie, de l’hématologie, de la nutrition, de la dermatologie ainsi que dans de multiples spécialités chirurgicales comme l’orthopédie et la chirurgie digestive. C’est un établissement de référence dans la prise en charge des urgences, des femmes enceintes et des patients âgés."

During the past decade, Lyon - URCOT conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lyon - URCOT" #1 collaborator was "Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Lyon - URCOT" are "Non Small Cell Lung Cancer Metastatic" (3 trials), "ALK Gene Rearrangement Positive" (1 trials), "BRAF V600E" (1 trials), "Lung Cancer" (1 trials) and "Melanoma" (1 trials). Many other conditions were trialed in "Lyon - URCOT" in a lesser frequency.

Most popular intervention types in "Lyon - URCOT" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Lorlatinib" (2 trials), "MEK162" (2 trials), "Atezolizumab" (1 trials), "Binimetinib 15 MG" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lyon - URCOT" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Lyon - URCOT". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Lyon - URCOT, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Lyon - URCOT, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".